Oral Oncology Clinic, Research Institute and Hospital, National Cancer Center, Republic of Korea.
Cancer Registration and Statistics Branch, National Cancer Center, Goyang, Gyeonggi, Republic of Korea.
Oral Oncol. 2017 Sep;72:73-79. doi: 10.1016/j.oraloncology.2017.07.006. Epub 2017 Jul 14.
Conditional relative survival (CRS) describes the survival chance of patients who have already survived for a certain period of time after diagnosis and treatment of cancer. Thus, CRS can complement the conventional 5-year relative survival, which does not consider the time patients have survived after their diagnosis. This study aimed to assess the 5-year CRS among Korean patients with oral cancer and the related risk factors.
We identified 15,329 oral cavity cancer cases with a diagnosis between 1993 and 2013 in the Korea Central Cancer Registry. The CRS rates were calculated according to sex, age, subsite, histology, and stage at diagnosis.
The 5-year relative survival was 57.2%, and further analysis revealed that the 5-year CRS increased during the first 2years and reached a plateau at 86.5% after 5years of survival. Women had better 5-year CRS than men after 5years of survival (90.0% vs. 83.3%), and ≤45-year-old patients had better 5-year CRS than older patient groups (93.3% vs. 86.4% or 86.7%). Subsite-specific differences in 5-year CRS were observed (tongue: 91% vs. mouth floor: 73.9%). Squamous cell carcinoma had a CRS of 87.3%, compared to 85.5% for other histological types. Localized disease had a CRS of 95.7%, compared to 87.3% for regional metastasis.
Patients with oral cavity cancer exhibited increasing CRS rates, which varied according to sex, age, subsite, histology, and stage at diagnosis. Thus, CRS analysis provides a more detailed perspective regarding survival during the years after the initial diagnosis or treatment.
条件相对生存率(CRS)描述了癌症诊断和治疗后已经存活一定时间的患者的生存机会。因此,CRS 可以补充传统的 5 年相对生存率,后者不考虑患者诊断后存活的时间。本研究旨在评估韩国口腔癌患者的 5 年 CRS 及其相关危险因素。
我们在韩国中央癌症登记处确定了 1993 年至 2013 年间诊断为 15329 例口腔癌病例。根据性别、年龄、部位、组织学和诊断时的分期计算 CRS 率。
5 年相对生存率为 57.2%,进一步分析显示,在生存的前 2 年内,5 年 CRS 增加,并在生存 5 年后达到 86.5%的平台期。女性在生存 5 年后的 5 年 CRS 优于男性(90.0%比 83.3%),≤45 岁患者的 5 年 CRS 优于年龄较大的患者组(93.3%比 86.4%或 86.7%)。不同部位的 5 年 CRS 存在差异(舌:91% vs. 口底:73.9%)。鳞状细胞癌的 CRS 为 87.3%,而其他组织学类型为 85.5%。局限性疾病的 CRS 为 95.7%,而区域性转移的 CRS 为 87.3%。
口腔癌患者的 CRS 呈上升趋势,其变化与性别、年龄、部位、组织学和诊断时的分期有关。因此,CRS 分析提供了更详细的角度来看待初始诊断或治疗后多年的生存情况。